Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

Changhua Christian Hospital14 enrolled

Overview

To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Punctate Inner Choroidopathy

Interventions

BevacizumabDRUG

Anti-vascular endothelial growth factor (VEGF)

Eligibility

Sex: ALLMin age: 20 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR). * Follow up over 4 years. Exclusion Criteria: * Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) without zonal outer retinopathy (ZOR).

Locations (1)

Changhua Christian Hospital

Changhua, Taiwan

Outcomes

Primary Outcomes

Wilcoxon Signed-Rank test

A statistical comparison of average of different time point

Time frame: Baseline, 4 year

Secondary Outcomes

visual acuity

visual acuity change in logMAR in different time point

Time frame: Baseline, 6 month, 12 month, 24 month, 36 month, 48 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.